CoreStock

Stock price

Market cap

At each fiscal year end, then the latest quarter end: closing price × shares outstanding.

Show table
Procter & Gamble market cap, annual
PeriodMarket cap
FY2017, ended Jun 30, 2017$222B
FY2018, ended Jun 30, 2018$194B
FY2019, ended Jun 30, 2019$274B
FY2020, ended Jun 30, 2020$297B
FY2021, ended Jun 30, 2021$328B
FY2022, ended Jun 30, 2022$344B
FY2023, ended Jun 30, 2023$358B
FY2024, ended Jun 30, 2024$388B
FY2025, ended Jun 30, 2025$373B
FY2026, ended Jun 30, 2026$341B
Trailing 12 months to Sep 30, 2026 (through Q1 FY2027)$337B

Revenue

By fiscal year, then the trailing 12 months

Show table
Procter & Gamble revenue, annual
PeriodRevenue
FY2017, ended Jun 30, 2017$65.1B
FY2018, ended Jun 30, 2018$66.8B
FY2019, ended Jun 30, 2019$67.7B
FY2020, ended Jun 30, 2020$71.0B
FY2021, ended Jun 30, 2021$76.1B
FY2022, ended Jun 30, 2022$80.2B
FY2023, ended Jun 30, 2023$82.0B
FY2024, ended Jun 30, 2024$84.0B
FY2025, ended Jun 30, 2025$84.3B
FY2026, ended Jun 30, 2026$87.0B
Trailing 12 months to Sep 30, 2026 (through Q1 FY2027)$87.9B

Net income and free cash flow

By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.

Show table
Procter & Gamble net income and free cash flow, annual
PeriodNet incomeFree cash flow
FY2017, ended Jun 30, 2017$15.3B$9.37B
FY2018, ended Jun 30, 2018$9.75B$11.2B
FY2019, ended Jun 30, 2019$3.90B$11.9B
FY2020, ended Jun 30, 2020$13.0B$14.3B
FY2021, ended Jun 30, 2021$14.3B$15.6B
FY2022, ended Jun 30, 2022$14.7B$13.6B
FY2023, ended Jun 30, 2023$14.7B$13.8B
FY2024, ended Jun 30, 2024$14.9B$16.5B
FY2025, ended Jun 30, 2025$16.0B$14.0B
FY2026, ended Jun 30, 2026$16.0B$15.1B
Trailing 12 months to Sep 30, 2026 (through Q1 FY2027)$16.0B$15.3B

Cash and cash equivalents

At each fiscal year end, then the latest quarter end.

Show table
Procter & Gamble cash and cash equivalents, annual
PeriodCash and cash equivalents
FY2017, ended Jun 30, 2017$5.57B
FY2018, ended Jun 30, 2018$2.57B
FY2019, ended Jun 30, 2019$4.24B
FY2020, ended Jun 30, 2020$16.2B
FY2021, ended Jun 30, 2021$10.3B
FY2022, ended Jun 30, 2022$7.21B
FY2023, ended Jun 30, 2023$8.25B
FY2024, ended Jun 30, 2024$9.48B
FY2025, ended Jun 30, 2025$9.56B
FY2026, ended Jun 30, 2026$9.94B
Trailing 12 months to Sep 30, 2026 (through Q1 FY2027)$15.4B

Total debt

At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.

Show table
Procter & Gamble total debt, annual
PeriodTotal debt
FY2017, ended Jun 30, 2017$31.6B
FY2018, ended Jun 30, 2018$31.3B
FY2019, ended Jun 30, 2019$30.1B
FY2020, ended Jun 30, 2020$34.7B
FY2021, ended Jun 30, 2021$32.0B
FY2022, ended Jun 30, 2022$31.5B
FY2023, ended Jun 30, 2023$34.6B
FY2024, ended Jun 30, 2024$32.5B
FY2025, ended Jun 30, 2025$34.5B
FY2026, ended Jun 30, 2026$34.1B
Trailing 12 months to Sep 30, 2026 (through Q1 FY2027)$38.9B

Shares outstanding

At each fiscal year end, then the latest quarter end, adjusted for splits. Down 9.1% since FY17.

Show table
Procter & Gamble shares outstanding, annual
PeriodShares outstanding
FY2017, ended Jun 30, 20172.55B
FY2018, ended Jun 30, 20182.49B
FY2019, ended Jun 30, 20192.50B
FY2020, ended Jun 30, 20202.49B
FY2021, ended Jun 30, 20212.43B
FY2022, ended Jun 30, 20222.39B
FY2023, ended Jun 30, 20232.36B
FY2024, ended Jun 30, 20242.35B
FY2025, ended Jun 30, 20252.34B
FY2026, ended Jun 30, 20262.32B
Trailing 12 months to Sep 30, 2026 (through Q1 FY2027)2.32B

Buybacks and new shares

By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.

Show table
Procter & Gamble share buybacks and issuance, annual
PeriodBought backPaid to employees
FY2017, ended Jun 30, 2017$5.20B$351M
FY2018, ended Jun 30, 2018$7.00B$395M
FY2019, ended Jun 30, 2019$5.00B$515M
FY2020, ended Jun 30, 2020$7.41B$558M
FY2021, ended Jun 30, 2021$11.0B$540M
FY2022, ended Jun 30, 2022$10.0B$528M
FY2023, ended Jun 30, 2023$7.35B$545M
FY2024, ended Jun 30, 2024$5.01B$562M
FY2025, ended Jun 30, 2025$6.50B$476M
FY2026, ended Jun 30, 2026$5.03B$524M
Trailing 12 months to Sep 30, 2026 (through Q1 FY2027)$5.03B$501M